ERBB2 and colorectal carcinoma: Among the CRC cases tested, 78.57% (11/14) of the cases were positive for HER2 (Score ≥ 2+; Figure 3A) whereas 21.43% (3/14) were negative for HER2 (≤1+; Figure 3B).